Cagrilintide monotherapy: 11.8% mean weight loss vs 2.3% placebo
You should seek prompt medical advice if you are currently using unlicensed peptides and experience any of the following: Persistent nausea, vomiting, or severe abdominal pain (which may indicate pancreatitis) Unexplained changes in heart rate or palpitations Symptoms of hypoglycaemia , such as shakiness, sweating, confusion, or dizziness Injection site redness, swelling, or signs of infection Unusual lumps, swelling in the neck, or difficulty swallowing (which may indicate thyroid changes) Mood changes, anxiety, or psychological distress related to body image or supplement use For urgent medical advice, contact NHS 111 (online at 111.nhs.uk or by telephone)
Still, its safety also hinges on several factors, including supervision and product quality
McLellan D, Selwyn M, Cooper I
Superagonist activity: Some research characterizes Ipamorelin as a "superagonist"producing greater GH release than equivalent doses of ghrelin itself
Post-inflammatory hyperpigmentation in darker skin is triggered by the inflammatory phase of healing